It has been proposed that the metal-drug complexes could be in fact the active agents displaying therapeutic effects of drugs. The characterization of the global formation equilibrium of complexes formed between metal ions and species with biological activity such as nonsteroidal anti-inflammatory drugs provides essential information to understand the mechanism of action of drugs. Since equilibrium constants determine the relative predominance of species, they provide crucial information to identify what complexes are more likely to be present in the system being responsible for the therapeutic effects of the drug. In this paper, the systems formed between copper and Indomethacin of different concentrations in ethanol or water were studied by UV-Vis spectrophotometry. The stoichiometry of the complexes Cu(II)–Indomethacin and their formation constants were investigated. Moreover, molecular structures of the Cu(II)–Indomethacin complexes were explored by means of the molecular modeling within the frame of the density functional theory.
In the field of Chemistry, it is essential to study molecules with biological activity on chronic degenerative diseases to design drugs that help to improve the health of people with diseases such as diabetes, arterial hypertension, rheumatoid arthritis, cancer, among others; and that in turn may have fewer side effects. Diabetes mellitus is a serious metabolic disorder that affects millions of people worldwide; due to the illness severe affectations, there is a great interest in improving pharmacological treatments (hypoglycemic drugs) used in this disease. Nowadays, it has been reported that metallodrugs and drug-cyclodextrin inclusion compounds have higher therapeutic activity than free drugs, with fewer side effects. In the present work, we compile, analyze, synthesize and discuss published information on the hypoglycemic drugs Metformin (C4H11N5), Chlorpropamide (C10H13ClN2O3S) and Glibenclamide (C23H28ClN3O5S) complexed with metal ions or included in cyclodextrins in aqueous solution. Nowadays, this type of complex should be widely studied for the treatment of type 2 diabetes mellitus. Physicochemical and thermodynamic properties, synthesis, mechanism of action, as well as analytical studies on the interaction of hypoglycemic agents with different complexing agents, are discussed.
28 April 2023 in Pädi Boletín Científico de Ciencias Básicas e Ingenierías del ICBI
La clorpropamida es un agente antidiabético perteneciente a la familia de las sulfonilureas, utilizado para el tratamiento de la Diabetes Mellitus Tipo 2, este fármaco presenta una baja solubilidad lo que conlleva a problemas de biodisponibilidad, una forma de solucionar esta complicación es utilizando ciclodextrinas, las cuales son oligosacáridos que presentan una forma toroidal semirrígida, poseen una cavidad hidrófoba, capaz de contener moléculas no polares en su interior formando un complejo de inclusión. La titulación calorimetría isotérmica es una técnica que permite conocer el perfil termodinámico de la reacción de inclusión entre la clorpropamida y la α-ciclodextrina (logK= 1.95 ± 0.01 M-1, ∆G0= −2.70 ± 0.005 kcal mol-1, ∆H0= −3.47 ± 0.06 kcal mol-1, −T∆S0= 0.763 ± 0.07 kcal mol-1), de igual forma permite realizar reacciones a diferentes temperaturas, con lo cual es posible determinar la capacidad calorífica de la inclusión (∆CP0= −0.119 kcal mol-1 K-1). Los resultados obtenidos muestran que la reacción es exotérmica, espontánea y que las interacciones que predominan son las hidrofóbicas.